fbpx
Civil Plaintiff

J&J must face Risperdal punitive damages trial

A Philadelphia judge decided that a new punitive damages trial will proceed in a Risperdal action that initially resulted in a $1 million-plus verdict in 2015 – above Johnson & Johnson’s attempt to dismiss the case through a motion for summary judgment.

Philadelphia County Court of Common Pleas Judge Arnold L. New denied the motion, which had been filed by Johnson & Johnson subsidiary Janssen Pharmaceuticals. The new punitive damages trial will begin on Sept. 16 in a Philadelphia courtroom.

Previously, on Sept. 14, 2018, New ruled that the plaintiffs in Risperdal litigations Stange v. Janssen Pharmaceuticals and Murray v. Janssen Pharmaceuticals would have the opportunity to apply the laws of their home states to try and obtain punitive damages from Janssen Pharmaceuticals, the developer of Risperdal.

A state court judge decided that a new punitive damages trial will proceed in a Risperdal action that initially resulted in a $1 million-plus verdict in 2015 – above Johnson & Johnson’s attempt to dismiss the case through a motion for summary judgment.

Philadelphia County Court of Common Pleas Judge Arnold L. New denied the motion on Wednesday, which had been filed by Johnson & Johnson subsidiary Janssen Pharmaceuticals.

The new punitive damages trial will begin on Sept. 16 in a Philadelphia courtroom.

Previously, on Sept. 14, 2018, New ruled that the plaintiffs in Risperdal litigations Stange v. Janssen Pharmaceuticals and Murray v. Janssen Pharmaceuticals would have the opportunity to apply the laws of their home states to try and obtain punitive damages from Janssen Pharmaceuticals, the developer of Risperdal.

Read More from Source

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button
    Close
    Close